Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and refreshing, because that oh-so-familiar routine of meetings, deadlines, and what-not has, of course, returned. This may be summertime, but the world does keep spinning, yes? So while you start to cope with this notion and the laundry lists of things to do, here are a few items of interest to help you along. We hope you have a smashing day and, as always, encourage you to keep in touch. A reminder: we accept all forms of secret communications and plans …

GlaxoSmithKline (GSK) is considering breaking up its businesses, according to The Financial Times. Glaxo chairman Philip Hampton has held talks with some of the shareholders about creating a standalone pharmaceuticals and vaccines company in the medium term, although the dispensing with the consumer unit might not happen for two or three years. The company is expected to outline its new approach for the division in the coming week when it reports second-quarter results on Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!